StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology ...
Nature1mon
200 mg/m 2 melphalan—the gold standard for multiple myeloma
Melphalan 200 mg/m 2 vs melphalan 100 mg/m 2 in newly diagnosed myeloma patients: a prospective multicenter phase 3 study. Blood 115 , 1873–1879 (2010). Article CAS PubMed Google Scholar ...